Prelude Announces Presentations at 2025 AACR Annual Meeting

• click to rate

  Posted by Two Blokes Apr 25 - Filed in Stock - 4 views
  
  Preclinical data elucidating the mechanism of action of PRT3789, Prelude's first-in-class, highly selective SMARCA2 degrader currently in early clinical development